Powered by Google

2011-18: RET IRD 01

Children and inhertable diseases
Drug research
Investigator Initiated Research
Inclusion open since 1-11-2011

An Open-Label, Phase 1b Safety/Proof-of-Concept Study to Evaluate the Effects of Oral QLT091001 in Subjects with Leber Congenital Amaurosis (LCA) or Retinitis Pigmentosa (RP) Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT).

By visiting eyehospital.nl you are accepting the use of cookies. Read more about cookies.

Hide this message